Evidence map›Paper›PMID 16541106›Full record

ArticleThe EMBO journal2006

Regulation of RNA polymerase III transcription during hypertrophic growth.

Sarah J Goodfellow, Fiona Innes, Louise E Derblay, W Robb MacLellan, Pamela H Scott, Robert J White

Open access · bronzeAbstract read
In one paragraph

Article in The EMBO journal, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
2.6field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Article
  6. tRNA dysregulation and disease.Nature reviews. Genetics · 2022
    Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Alcohol Intake and Abnormal Expression of Brf1 in Breast Cancer.Oxidative medicine and cellular longevity · 2019
    Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Sarah J GoodfellowDivision of Biochemistry and Molecular Biology, Institute of Biomedical and Life Sciences, University of Glasgow, Glasgow, UK.
Fiona Innes
Louise E Derblay
W Robb MacLellan
Pamela H Scott
Robert J White
University of Glasgow · GBUniversity of California, Los Angeles · US

Funding

GENETIC ANALYSIS OF CARDIAC TERMINAL DIFFERENTIATIONR01HL062448 · NHLBI · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MACLELLAN, WILLIAM ROBB · 2000 to 2003
$904k
NHLBI NIH HHS R01 HL062448NHLBI NIH HHS R01 HL62448Wellcome TrustWellcome Trust 062625Wellcome Trust 068710
6 · The paper itself

Abstract

The cell division-independent growth of terminally differentiated cardiomyocytes is commonly associated with cardiovascular disease. We demonstrate that it is accompanied by a substantial rise in transcription by RNA polymerase (pol) III, which produces essential components of the biosynthetic apparatus, including 5S rRNA and tRNAs. This increase in transcription is achieved by changes in both the activity and level of the essential pol III-specific transcription factor TFIIIB. Erk and c-Myc, which directly activate TFIIIB in proliferating fibroblasts, also induce pol III transcription in growing cardiomyocytes. Furthermore, hypertrophic stimulation increases expression of the essential TFIIIB subunit Brf1, an effect not seen when fibroblasts proliferate. Erk mediates this induction of Brf1 expression and therefore contributes in at least two ways to pol III transcriptional activation during hypertrophy. Increased production of tRNA and 5S rRNA will contribute to the enhanced translational capacity required to sustain hypertrophic growth.

Indexed as

Cell EnlargementTranscription, GeneticAnimalsCardiomegalyCells, CulturedEnzyme ActivationExtracellular Signal-Regulated MAP KinasesMiceMice, TransgenicMyocytes, CardiacProtein SubunitsProto-Oncogene Proteins c-mycRatsRNA Polymerase IIIRNA, Ribosomal, 5SRNA, TransferExtracellular Signal-Regulated MAP KinasesProtein SubunitsProto-Oncogene Proteins c-mycRNA Polymerase IIIRNA, Ribosomal, 5SRNA, TransferTranscription Factor TFIIIB

Identifiers

PMID16541106
PMCPMC1440310
OpenAlexW2134123734

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.